1 Protection from preconditioning (PC) wanes and is eventually lost when multiple bouts of short ischemia or a prolonged reperfusion interval precedes the following sustained ischemia. The activation of mitochondrial K ATP channels plays a pivotal role in the intracellular signaling of PC. We tested whether the K ATP channel opener nicorandil (nic) preserves the given protection from PC in conditions where this benefit decays and is lost. 2 Eight groups of rabbits were divided into two equal series of experiments, one without nic (placebo) and one with nic treatment. Nic was given orally for 5 consecutive days in a dose of 5 mg kg À1 d À1 . In a second step, four additional groups were treated with nic plus the K ATP channel blocker 5HD and 1 additional control group with nitroglycerin only. All the animals were anesthetized and then subjected to 30 min of myocardial ischemia and 2 h of reperfusion with one of the following interventions before the sustained ischemia: Control groups to no intervention; 3PC groups to three cycles of 5-min ischemia-10-min reperfusion; 8PC groups to eight cycles of 5-min ischemia -10-min reperfusion; and 3PC90 groups to the same interventions as the 3PC groups but with a prolonged (90 min) intervening reperfusion interval before the sustained ischemia. The infarcted and the risk areas were expressed in percent. 3 There was no significant change in infarct size between the placebo, the nic and the 5HD-nic in the control groups (41.574.7, 43.977.1 and 48.776.4%) and 3PC groups (10.373.4, 12.273.9 and 12.674.5%). However, there was a significant decrease after nic treatment in groups 8PC (47.778.8% vs 13.072.6%, Po0.01) and 3PC90 (37.376.0% vs 14.272.4%, Po0.01), which was abrogated (38.274.7 and 42.774.4%, respectively, for 8PC and 3PC90 groups). Nitroglycerin had no effect on infarct size (39.173.1%, P ¼ NS vs other controls). 4 Oral treatment with nic recaptures the waned protection of PC, both after repetitive bouts of short ischemia or after a prolonged reperfusion interval, preserving the initially obtained benefit. Nic by itself is insufficient to initiate PC in vivo.